$SRNE This is the x-factor. Hoping for a big ASH reveal of preferably US biopharmas. "SRNE says it is in active late-stage licensing and collaboration discussions with leading biopharma companies for its immuno-oncology products, and believes the pending transactions alone represent potential value creation that significantly exceeds the proposal."
  • 1
  • 1